Opko Health, Inc.
OPK
$1.38
-$0.02-1.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.57% | -18.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.57% | -18.34% | |||
| Cost of Revenue | -0.31% | 6.78% | |||
| Gross Profit | 61.81% | -78.28% | |||
| SG&A Expenses | 0.86% | -11.85% | |||
| Depreciation & Amortization | -2.10% | -2.37% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.15% | 0.16% | |||
| Operating Income | 10.70% | -102.69% | |||
| Income Before Tax | -121.47% | -309.83% | |||
| Income Tax Expenses | -144.00% | -127.55% | |||
| Earnings from Continuing Operations | -119.55% | -582.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -119.55% | -582.02% | |||
| EBIT | 10.70% | -102.69% | |||
| EBITDA | 15.40% | -380.01% | |||
| EPS Basic | -87.09% | -586.47% | |||
| Normalized Basic EPS | -93.54% | -150.00% | |||
| EPS Diluted | -87.09% | -672.16% | |||
| Normalized Diluted EPS | -93.54% | -170.33% | |||
| Average Basic Shares Outstanding | 17.34% | -0.77% | |||
| Average Diluted Shares Outstanding | 17.34% | -29.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||